Skip Navigation

Vaccine Safety Bibliography - October 2012

1.   Flu vaccination standards set for ASCs and OBSs. Bull Am Coll Surg. 2012 Sep; 97(9):69.

2.   Patient information. Should I get the shingles vaccine? JAAPA. 2012 Sep; 25(9):66.

3.   Adams WG. Text messaging increases receipt of influenza vaccine among low-income, urban children. J Pediatr. 2012 Sep; 161(3):568-9.

4.   Adegbola R, Nesin M, Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S28-32.

5.   Aikawa N, Campos L, Goldenstein-Schainberg C, Saad C, Ribeiro A, Bueno C, Precioso A, Timenetsky M, Silva C, Bonfá E. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scand J Rheumatol. 2012 Sep 20. [Epub ahead of print].

6.   Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR. Antibody responses to individual Bordetella pertussis fimbrial antigens Fim2 or Fim3 following immunisation with five component acellular pertussis vaccine or disease. Clin Vaccine Immunol. 2012 Sep 5. [Epub ahead of print].

7.   Allwinn R, Bickel M, Lassmann C, Wicker S, Friedrichs I. "Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?" Med Microbiol Immunol. 2012 Sep 19. [Epub ahead of print].

8.   Ambrose CS, Wu X, Jones T, Mallory RM. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine. 2012 Sep 18. [Epub ahead of print].

9.   Andrews N. Epidemiological designs for vaccine safety assessment: Methods and pitfalls. Biologicals. 2012 Sep; 40(5):389-92.

10.  Andrews NJ, Waight PA, George RC, Slack MP, Miller E. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine. 2012 Sep 18. pii: S0264-410X(12)01329-1. doi: 10.1016/j.vaccine.2012.09.019. [Epub ahead of print].

11.  Araz OM, Galvani A, Meyers LA. Geographic prioritization of distributing pandemic influenza vaccines. Health Care Manag Sci. 2012 Sep; 15(3):175-87.

12.  Arroyo JC. Unsettled issues of zostavax vaccine. Clin Infect Dis. 2012 Sep; 55(6):889-90.

13.  Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine. 2012 Sep 20.  [Epub ahead of print].

14.  Ault KA, Heine RP, Riley LE. Programmatic and research priorities for improving influenza immunization of pregnant women. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S75-7.

15.  Baldwin AS, Bruce CM, Tiro JA. Understanding how Mothers of Adolescent Girls  Obtain Information About the hpv Vaccine: Associations Between Mothers' Health Beliefs, Information Seeking, and Vaccination Intentions in an Ethnically Diverse Sample. J Health Psychol. 2012 Sep 19. [Epub ahead of print].

16.  Baleta AF, van den Heever J, Burnett RJ. Meeting the need for advocacy, social mobilisation and communication in the introduction of three new vaccines in South Africa - Successes and challenges. Vaccine. 2012 Sep 7; 30 Suppl 3:C66-71.

17.  Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Vaccine. 2012 Sep 13. [Epub ahead of print].

18.  Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine. 2012 Sep 28. [Epub ahead of print].

19.  Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S38-46.

20.  Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C. Capsular switching in Group B streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis. 2012 Sep 21. [Epub ahead of print].

21.  Benhafid M, Rguig A, Trivedi T, Elqazoui M, Teleb N, Mouane N, Maltouf AF, Parashar U, Patel M, Aouad RE. Monitoring of rotavirus vaccination in Morocco: Establishing the baseline burden of rotavirus disease. Vaccine. 2012 Sep 7. [Epub ahead of print].

22.  Berndsen MR, Erlendsdóttir H, Gottfredsson M. Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. Clin Microbiol Infect. 2012 Sep; 18(9):918-23.

23.  Bielicki JA, Achermann R, Berger C. Timing of measles immunization and effective population vaccine coverage. Pediatrics. 2012 Sep; 130(3):e600-6.

24.  Black S, Egan W, Lambert PH. Post-licensure evaluation of vaccine safety: Current status and future directions. Symposium organised by the International Alliance for Biological Standardization (IABS) in Barcelona, Spain, 27-28 April 2011. Biologicals. 2012 Sep; 40(5):382-3.

25.  Blaizeau F, Lasserre A, Rossignol L, Blanchon T, Kernéis S, Hanslik T, Levy-Bruhl D. Practices of French family physicians concerning varicella vaccination for teenagers. Med Mal Infect. 2012 Sep; 42(9):429-34.

26.  Blanchard-Rohner G, Meier S, Ryser J, Schaller D, Combescure C, Yudin MH, Burton-Jeangros C, de Tejada BM, Siegrist CA. Acceptability of maternal immunization against influenza: the critical role of obstetricians. J Matern Fetal Neonatal Med. 2012 Sep; 25(9):1800-9.

27.  Blecher MS, Meheus F, Kollipara A, Hecht R, Cameron NA, Pillay Y, Hanna L. Financing vaccinations - The South African experience. Vaccine. 2012 Sep 7; 30 Suppl 3:C79-86.

28.  Bonhoeffer J, Black S, Izurieta H, Zuber P, Sturkenboom M. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe. Biologicals. 2012 Sep; 40(5):393-7.

29.  Borrow R. Advances with vaccination against Neisseria meningitidis. Trop Med  Int Health. 2012 Sep 4. [Epub ahead of print].

30.  Briere EC, Jackson M, Shah SG, Cohn AC, Anderson RD, Macneil JR, Coronado FM, Mayer LW, Clark TA, Messonnier NE. Haemophilus influenzae Type b Disease and Vaccine Booster Dose Deferral, United States, 1998-2009. Pediatrics. 2012 Sep; 130(3):414-20.

31.  Brigham KS, Woods ER, Steltz SK, Sandora TJ, Blood EA. Randomized controlled  trial of an immunization recall intervention for adolescents. Pediatrics. 2012 Sep; 130(3):507-14.

32.  Brownfield E, Marsden JE, Iverson PJ, Zhao Y, Mauldin PD, Moran WP. Point of  care experience with pneumococcal and influenza vaccine documentation among persons aged ≥65 years: High refusal rates and missing information. Am J Infect Control. 2012 Sep; 40(7):672-4.

33.  Burgess L, Southern KW. Pneumococcal vaccines for cystic fibrosis. Cochrane Database Syst Rev. 2012 Sep 12; 9:CD008865.

34.  Burnett RJ, Larson HJ, Moloi MH, Tshatsinde EA, Meheus A, Paterson P, François G. Addressing public questioning and concerns about vaccination in South Africa: A guide for healthcare workers. Vaccine. 2012 Sep 7; 30 Suppl 3:C72-8.

35.  Burton J, Billings L, Cummings DA, Schwartz IB. Disease persistence in epidemiological models: the interplay between vaccination and migration. Math Biosci. 2012 Sep; 239(1):91-6.

36.  Byrne C, Walsh J, Kola S, Sarma KM. Predicting intention to uptake H1N1 influenza vaccine in a university sample. Br J Health Psychol. 2012 Sep; 17(3):582-95.

37.  Cameron NA. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa? Vaccine. 2012 Sep 7; 30 Suppl 3:C58-60.

38.  Caplan AL. Quantifying the efficacy of influenza vaccines. Lancet Infect Dis. 2012 Sep; 12(9):656-7.

39.  Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouédraogo R, Kandolo D, Bougoudogo F, Sow S, Bonte L. Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine. PLoS One. 2012; 7(9):e46019.

40.  Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among pregnant women - 2011-12 influenza season, United States. MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:758-63.

41.  Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among health-care personnel - 2011-12 influenza season, United States. MMWR Morb Mortal Wkly Rep. 2012 Sep 28; 61:753-7.

42.  Centers for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses - worldwide, april 2011-june 2012. MMWR Morb Mortal Wkly Rep. 2012 Sep 21; 61:741-6.

43.  Chan TC, Yap YH, Hung FN, Shea YF, Chu LW, Luk KH, Woo CY, Chan HW. The Efficacy of Influenza Vaccination is Reduced in Nursing Home Older Adults With Moderate to Severe Renal Impairment. J Am Med Dir Assoc. 2012 Sep 27. [Epub ahead of print].

44.  Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW. Functional Status of Older Nursing Home Residents Can Affect the Efficacy of Influenza Vaccination. J Gerontol A Biol Sci Med Sci. 2012 Sep 11. [Epub ahead of print].

45.  Chang YC, Chou YJ, Liu JY, Yeh TF, Huang N. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan - A representative population-based comparative study. J Infect. 2012 Sep; 65(3):231-8.

46.  Chao C, Jacobsen SJ. Evaluation of autoimmune safety signal in observational  vaccine safety studies. Hum Vaccin Immunother. 2012 Sep 1; 8(9). [Epub ahead of print].

47.  Chapman GB, Li M, Vietri J, Ibuka Y, Thomas D, Yoon H, Galvani AP. Using game theory to examine incentives in influenza vaccination behavior. Psychol Sci. 2012 Sep 1; 23(9):1008-15.

48.  Chauke-Moagi BE, Mumba M. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs. Vaccine. 2012 Sep 7; 30 Suppl 3:C3-8.

49.  Choe YJ, Hu JK, Song KM, Cho H, Yoon HS, Kim ST, Lee HJ, Kim K, Bae GR, Lee JK. Evaluation of an expanded case definition for vaccine-modified measles in a school outbreak in South Korea in 2010. Jpn J Infect Dis. 2012 Sep; 65(5):371-5.

50.  Chung E, Sen J. The ongoing pursuit of a prophylactic HSV vaccine. Rev Med Virol. 2012 Sep; 22(5):285-300.

51.  Clifford HD, Hayden CM, Khoo SK, Naniche D, Mandomando IM, Zhang G, Richmond  P, Le Souëf PN. Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine. 2012 Sep 21; 30(43):6180-5.

52.  Closser S, Rosenthal A, Parris T, Maes K, Justice J, Cox K, Luck MA, Landis RM, Grove J, Tedoff P, Venczel L, Nsubuga P, Kuzara J, Neergheen V. Methods for evaluating the impact of vertical programs on health systems: protocol for a study on the impact of the global polio eradication initiative on strengthening routine immunization and primary health care. BMC Public Health. 2012 Sep 1; 12(1):728. [Epub ahead of print].

53.  Cohen R, Levy C. [Meningococcal vaccines: from polysaccharide to conjugate vaccines]. Arch Pediatr. 2012 Sep; 19 Suppl 2:S61-4.

54.  Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V,  McNeil SA. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine. 2012 Sep 28; 30(44):6287-93.

55.  Crawley J, Sismanidis C, Goodman T, Milligan P; WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization  in infants receiving Intermittent Preventive Treatment for malaria. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials. Lancet. 2012 Sep 15; 380(9846):1001-10.

56.  Cronin J, Scorr A, Russell S, McCoy S, Walsh S, O'Sullivan R. A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis. Acta Paediatr. 2012 Sep; 101(9):941-5.

57.  Curry DM, Brown C, Wrona S. Effectiveness of oral sucrose for pain management in infants during immunizations. Pain Manag Nurs. 2012 Sep; 13(3):139-49.

58.  Dawn Co M, Cruz J, Takeda A, Ennis F, Terajima M. Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals. Hum Vaccin Immunother. 2012 Sep 1; 8(9). [Epub ahead of print].

59.  Dayan GH, Bevilacqua J, Coleman D, Buldo A, Risi G. Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age. Vaccine. 2012 Sep 7. [Epub ahead of print].

60.  de Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M. Estimation of Pertussis Household Transmission Rates and the Impact of Cocooning Vaccination Strategies on Infant Pertussis. Epidemiology. 2012 Sep 26.  [Epub ahead of print].

61.  de la Fuente IG, Wagner N, Siegrist CA, Posfay-Barbe KM. Tetanus Immunity as  a Surrogate for Past DTP Immunization in Migrant Children. Pediatr Infect Dis J.  2012 Sep 20. [Epub ahead of print].

62.  de Vos van Steenwijk PJ, Ramwadhdoebe TH, Löwik MJ, van der Minne CE, Berends-van der Meer DM, Fathers LM, Valentijn AR, Oostendorp J, Fleuren GJ, Hellebrekers BW, Welters MJ, van Poelgeest MI, Melief CJ, Kenter GG, van der Burg SH. A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. Cancer  Immunol Immunother. 2012 Sep; 61(9):1485-92.

63.  Del Bo' C, Riso P, Brambilla A, Gardana C, Rizzolo A, Simonetti P, Bertolo G, Klimis-Zacas D, Porrini M. Blanching Improves Anthocyanin Absorption from Highbush Blueberry ( Vaccinium corymbosum L.) Purée in Healthy Human Volunteers:  A Pilot Study. J Agric Food Chem. 2012 Sep 12; 60(36):9298-304.

64.  Delves MJ, Ramakrishnan C, Blagborough AM, Leroy D, Wells TN, Sinden RE. A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines. Int J Parasitol. 2012 Sep 27. [Epub ahead of print].

65.  Denny L, Kim J. European cost-effectiveness analysis of cervical screening strategies for women not vaccinated for HPV: in many scenarios primary HPV screening is preferable to primary cytology screening in women aged over 30 years. Evid Based Nurs. 2012 Sep 28. [Epub ahead of print].

66.  Derber CJ, Shankaran S. Health-Care Worker Vaccination for Influenza: Strategies and Controversies. Curr Infect Dis Rep. 2012 Sep 1. [Epub ahead of print].

67.  Des Roches A, Paradis L, Gagnon R, Lemire C, Bégin P, Carr S, Chan ES, Paradis J, Frenette L, Ouakki M, Benoît M, De Serres G; on behalf of the PCIRN (Public Health Agency of Canada/Canadian Institutes of Health Research Influenza  Research Network). Egg-allergic patients can be safely vaccinated against influenza. J Allergy Clin Immunol. 2012 Sep 26. [Epub ahead of print].

68.  Dhamodharan A, Proano RA. Determining the optimal vaccine vial size in developing countries: a Monte Carlo simulation approach. Health Care Manag Sci. 2012 Sep; 15(3):188-96.

69.  Dommergues MA. [Meningococcal serogroup B vaccines]. Arch Pediatr. 2012 Sep; 19 Suppl 2:S65-9.

70.  Dransfield MT, Harnden S, Burton RL, Albert RK, Bailey WC, Casaburi R, Connett J, Cooper JA, Criner GJ, Curtis JL, Han MK, Make B, Marchetti N, Martinez FJ, McEvoy C, Nahm MH, Niewoehner DE, Porszasz J, Reilly J, Scanlon PD, Scharf SM, Sciurba FC, Washko GR, Woodruff PG, Lazarus SC; for the NIH COPD Clinical Research Network. Long-term Comparative Immunogenicity of Protein Conjugate and Free Polysaccharide Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease. Clin Infect Dis. 2012 Sep; 55(5):e35-e44.  

71.  Dudareva-Vizule S, Koch J, An der Heiden M, Oberle D, Keller-Stanislawski B,  Wichmann O. Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany. Hum Vaccin Immunother. 2012 Sep 7; 8(10). [Epub ahead of print].

72.  Dulgheroff AC, Figueiredo EF, Moreira LP, Moreira KC, Moura LM, Gouvêa VS, Domingues AL. Distribution of rotavirus genotypes after vaccine introduction in the Triângulo Mineiro region of Brazil: 4-Year follow-up study. J Clin Virol. 2012 Sep; 55(1):67-71.

73.  Eisenstein M. US funds vaccine centers for biodefense. Nat Biotechnol. 2012 Sep 10;30(9):808.

74.  El-Makhzangy AM, Ismail NM, Galal SB, Sobhy TS, Hegazy AA. Can vaccination against pneumococci prevent otitis media with effusion? Eur Arch Otorhinolaryngol. 2012 Sep; 269(9):2021-6.

75.  Ernsting A, Schwarzer R, Lippke S, Schneider M. "I Don't Need a Flu Shot Because I Lead a Healthy Lifestyle": Compensatory Health Beliefs Make Vaccination Less Likely. J Health Psychol. 2012 Sep 5. [Epub ahead of print].

76.  Eurosurveillance editorial team. Updated version of ECDC Guidance on human papillomavirus vaccines in Europe available. Euro Surveill. 2012 Sep 13; 17(37).

77.  Everett DB, Cornick J, Denis B, Chewapreecha C, Croucher N, Harris S, Parkhill J, Gordon S, Carrol ED, French N, Heyderman RS, Bentley SD. Genetic Characterisation of Malawian Pneumococci Prior to the Roll-Out of the PCV13 Vaccine Using a High-Throughput Whole Genome Sequencing Approach. PLoS One. 2012; 7(9):e44250.

78.  Fairhead T, Hendren E, Tinckam K, Rose C, Sherlock CH, Shi L, Crowcroft NS, Gubbay JB, Landsberg D, Knoll G, Gill J, Kumar D. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. Transpl Infect Dis. 2012 Sep 24. [Epub ahead of print].

79.  Fontanesi J, Jue-Leong S. Logistical and fiscal sustainability of a school-based, pharmacist-administered influenza vaccination program. J Am Pharm Assoc (2003). 2012 Sep 1; 52(5):e74-9.

80.  Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB. Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations. J Infect Dis. 2012 Sep; 206(6):828-37.

81.  Gainforth HL, Latimer AE. Risky business: Risk information and the moderating effect of message frame and past behaviour on women's perceptions of the Human Papillomavirus vaccine. J Health Psychol. 2012 Sep; 17(6):896-906.

82.  Gans HA. The status of live viral vaccination in early life. Vaccine. 2012 Sep 28. [Epub ahead of print].

83.  García-Basteiro AL, Llupià A, Mena G, Bayas JM, Trilla A. Quantifying the efficacy of influenza vaccines. Lancet Infect Dis. 2012 Sep; 12(9):657-8.

84.  Garnock-Jones KP, Giuliano AR. Quadrivalent Human Papillomavirus (HPV) Types  6, 11, 16, 18 Vaccine For the Prevention of Genital Warts in Males†: Profile Report. Drugs R D. 2012 Sep 28. [Epub ahead of print].

85.  Gauld NJ, Jennings LC, Frampton C, Huang QS. Five years of non-prescription  oseltamivir: effects on resistance, immunization and stockpiling. J Antimicrob Chemother. 2012 Sep 4. [Epub ahead of print].

86.  Gendrel D. [Heterogeneity of vaccine policies in meningococcal prevention].  Arch Pediatr. 2012 Sep; 19 Suppl 2:S70-6.

87.  Gessner BD. Ethnic disparities in influenza vaccination in Canada. CMAJ. 2012 Sep 10. [Epub ahead of print].

88.  Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines. Influenza Other Respi Viruses. 2012 Sep 3. [Epub ahead of print].

89.  Gherardi G, D'Ambrosio F, Visaggio D, Dicuonzo G, Del Grosso M, Pantosti A.  Serotype and Clonal Evolution of Penicillin-Nonsusceptible Invasive Streptococcus pneumoniae in the 7-Valent Pneumococcal Conjugate Vaccine Era in Italy. Antimicrob Agents Chemother. 2012 Sep; 56(9):4965-8.

90.  Gilbert SC. Advances in the development of universal influenza vaccines. Influenza Other Respi Viruses. 2012 Sep 24. [Epub ahead of print].

91.  Goldman G. Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: Was there a synergistic fetal toxicity associated with the two-vaccine 2009/2010 season? Hum Exp Toxicol. 2012 Sep 27. [Epub ahead of print].

92.  Grogg SE. Update on Advisory Committee on Immunization Practices (ACIP) Vaccine Recommendations, June 2012. J Am Osteopath Assoc. 2012 Sep; 112(9):585-6.  

93.  Gulland A. China is nearly ready to produce vaccines for developing world. BMJ. 2012 Sep 18; 345:e6290.

94.  Gupta SK, Sosler S, Lahariya C. Introduction of Haemophilus Influenzae type  b (Hib) as Pentavalent(DPT-HepB-Hib) Vaccine in Two States of India. Indian Pediatr. 2012 Sep 8;49(9):707-9.

95.  Guérin-El Khourouj V, Duchamp M, Krivine A, Pédron B, Ouachée-Chardin M, Yakouben K, Frémond ML, Baruchel A, Dalle JH, Sterkers G. Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantation. Hum Immunol. 2012 Sep; 73(9):884-90.

96.  Halstead SB. Dengue vaccine development: a 75% solution? Lancet. 2012 Sep 10. pii: S0140-6736(12)61510-4. [Epub ahead of print].

97.  Haralambieva IH, Oberg AL, Dhiman N, Ovsyannikova IG, Kennedy RB, Grill DE,  Jacobson RM, Poland GA. High dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination. J Infect Dis. 2012 Sep 4. [Epub ahead of print].

98.  Hatz C. Editorial commentary: boosting Japanese encephalitis vaccine. Clin Infect Dis. 2012 Sep; 55(6):835-6.

99.  Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, Della Cioppa G. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol. 2012 Sep; 207(3):177.e1-8.

100. Hemming M, Vesikari T. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis. Pediatr Infect Dis J. 2012 Sep; 31(9):992-4.

101. Hendriks J. Technology transfer in human vaccinology: A retrospective review on public sector contributions in a privatizing science field. Vaccine. 2012 Sep  28;30(44):6230-40.

102. Herman JS, Hill DR. Vaccine-preventable diseases and their prophylaxis. Infect Dis Clin North Am. 2012 Sep; 26(3):595-608.  

103. Hirve S, Bavdekar A, Juvekar S, Benn CS, Nielsen J, Aaby P. Non-specific and sex-differential effects of vaccinations on child survival in rural western India. Vaccine. 2012 Sep 26. pii: S0264-410X(12)01346-1. [Epub ahead of print].

104. Hollander D. Provider Recommendation Linked to Adolescent-Females' HPV Vaccination. Perspect Sex Reprod Health. 2012 Sep; 44(3):208-9.

105. Hollmeyer H, Hayden F, Mounts A, Buchholz U. Review: interventions to increase influenza vaccination among healthcare workers in hospitals. Influenza Other Respi Viruses. 2012 Sep 18. [Epub ahead of print].

106. Holmgren J. A case for control of cholera in Africa by vaccination. Lancet Infect Dis. 2012 Sep 3. [Epub ahead of print].

107. Horien C, Grose C. Neurovirulence of varicella and the live attenuated varicella vaccine virus. Semin Pediatr Neurol. 2012 Sep; 19(3):124-9.

108. Hothersall EJ, de Bellis-Ayres S, Jordan R. Factors associated with uptake of pandemic influenza vaccine among general practitioners and practice nurses in  Shropshire, UK. Prim Care Respir J. 2012 Sep; 21(3):302-7.

109. Hsieh YC, Chiu CH, Chang KY, Huang YC, Chen CJ, Kuo CY, Chen PY, Hwang KP, Lin TY. The Impact of the Heptavalent Pneumococcal Conjugate Vaccine on Risk Factors for Streptococcus pneumoniae Carriage in Children. Pediatr Infect Dis J.  2012 Sep; 31(9):e163-e168.

110. Hughes B, Hayden F, Perikov Y, Hombach J, Tam JS. Report of the 5th meeting  on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011. Vaccine. 2012  Sep 11. [Epub ahead of print].

111. Ibraheem M, Marin M, Leung J, Bryce CH, Schmid DS, Zaki SR, Drew C, Liu L, Smelser C. Fatal Wild-type Varicella-Zoster Virus Encephalitis without a Rash in  a Vaccinated Child. Pediatr Infect Dis J. 2012 Sep 13. [Epub ahead of print].

112. Ihan A, Pinchuk IV, Beswick EJ. Inflammation, Immunity, and Vaccines for Helicobacter pylori Infection. Helicobacter. 2012 Sep; 17 Suppl 1:16-21.

113. Iyer V, Hu L, Liyanage MR, Esfandiary R, Reinisch C, Meinke A, Maisonneuve J, Volkin DB, Joshi SB, Middaugh CR. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae. J Pharm Sci. 2012 Sep; 101(9):3078-90.

114. Jabbal-Gill I, Watts P, Smith A. Chitosan-based delivery systems for mucosal vaccines. Expert Opin Drug Deliv. 2012 Sep; 9(9):1051-67.

115. Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, Kotloff KL, Rouphael N, Noah DL, Hill H, Wolff MC. Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons. J Infect Dis. 2012 Sep;206(6):811-20.

116. Jacobs AL. Liability and maternal immunization: in utero injury claims in the VICP. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S63-6.

117. Jamieson DJ, Kissin DM, Bridges CB, Rasmussen SA. Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S17-20.

118. Jamieson DJ, Rasmussen SA. The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them? Am J Obstet Gynecol. 2012 Sep; 207(3):145-6.

119. Jokinen J, Palmu AA, Kilpi T. Acute Otitis Media replacement and recurrence  in the Finnish Otitis Media (FinOM) Vaccine trial. Clin Infect Dis. 2012 Sep 14.  [Epub ahead of print].

120. Joshua PR, Smith MM, Koh AS, Woodland LA, Zwi K. Australian Population Cohort Study of Newly Arrived Refugee Children Relevant to Pre-Departure Measles  and Rubella Vaccination? Pediatr Infect Dis J. 2012 Sep 4. [Epub ahead of print].

121. Jönsson G, Lood C, Gullstrand B, Holmström E, Selander B, Braconier JH, Sturfelt G, Bengtsson AA, Truedsson L. Vaccination against encapsulated bacteria  in hereditary C2 deficiency results in antibody response and opsonization due to  antibody-dependent complement activation. Clin Immunol. 2012 Sep; 144(3):214-27.

122. Kelly NR, Kromelis MR, Jordan D, Merryman R, Siegel JD. Feasibility of delivering influenza vaccine to household contacts of pediatric patients in a residents' continuity clinic. Am J Infect Control. 2012 Sep; 40(7):627-31.

123. Kennedy ED, Ahluwalia IB, Ding H, Lu PJ, Singleton JA, Bridges CB. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S9-S16.

124. Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Jacobson RM, Poland GA. Genome-wide genetic associations with IFNγ response to smallpox vaccine. Hum Genet. 2012 Sep; 131(9):1433-51.

125. Kennedy RB, Ovsyannikova IG, Shane Pankratz V, Haralambieva IH, Vierkant RA, Poland GA. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet. 2012 Sep; 131(9):1403-21.

126. Kharbanda EO, Vazquez-Benitez G, Shi WX, Lipkind H, Naleway A, Molitor B, Kuckler L, Olsen A, Nordin JD. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S47-51.

127.  Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis. 2012 Sep 3. [Epub ahead of print].

128.  Khromava A, Cohen CJ, Mazur M, Kanesa-Thasan N, Crucitti A, Seifert H. Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S52-6.

129.  Kim DS, Shin SH, Lee HJ, Hong YJ, Lee SY, Choi KM, Oh CE, Kim KH, Juergens C, Patterson S, Giardina PC, Gruber WC, Emini EA, Scott DA. Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Given to Korean Children Receiving Routine Pediatric Vaccines. Pediatr Infect Dis J. 2012 Sep 24. [Epub ahead of print].

130. Kimm KL. Should I get the shingles vaccine? JAAPA. 2012 Sep; 25(9):65.

131. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J  Med. 2012 Sep 13;367(11):1012-9.

132. Kluthe M, Herrera A, Blanca H, Leung J, Bialek SR, Schmid DS. Neonatal vaccine-strain varicella-zoster virus infection 22 days after maternal postpartum vaccination. Pediatr Infect Dis J. 2012 Sep; 31(9):977-9.

133. Kohler S, Bethke N, Böthe M, Sommerick S, Frentsch M, Romagnani C, Niedrig M, Thiel A. The early cellular signatures of protective immunity induced by live  viral vaccination. Eur J Immunol. 2012 Sep; 42(9):2363-73.

134. Kolibab K, Derrick SC, Jacobs WR, Morris SL. Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations. J Microbiol Methods. 2012 Sep; 90(3):245-9.

135. Kondo M, Yamamura M, Hoshi SL, Okubo I. Demand for pneumococcal vaccination  under subsidy program for the elderly in Japan. BMC Health Serv Res. 2012 Sep 12; 12(1):313. [Epub ahead of print]

136. Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning Antibody Levels and Avidity: Implications for MMR Vaccine Induced Protection. J Infect Dis. 2012  Sep 10. [Epub ahead of print].

137. Kopel E, Oren G, Sidi Y, David D. Inadequate antibody response to rabies vaccine in immunocompromised patient. Emerg Infect Dis. 2012 Sep; 18(9):1493-5.

138. Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, Knäuper B, Rosberger Z. Human papillomavirus vaccination intentions and uptake in college women. Health Psychol. 2012 Sep;31(5):685-93.

139. Kumagai T, Kiyono H. Summary for symposium I on the development of a more efficacious influenza vaccine held at the 15th annual meeting of the Japanese society for vaccinology, Tokyo, 2011. Vaccine. 2012 Sep 28; 30(44):6338-9.

140. Kusters MA, Bok VL, Bolz W, Huijskens E, Peeters M, de Vries E. Influenza A/H1N1 Vaccination Response is Inadequate in Down Syndrome Children When the Latest Cut-Off Values Are Used. Pediatr Infect Dis J. 2012 Sep 14. [Epub ahead of print].

141. Lanata CF, Andrade T, Gil AI, Terrones C, Valladolid O, Zambrano B, Saville  M, Crevat D. Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru. Vaccine. 2012 Sep 7; 30(41):5935-41.

142. Lau AY, Sintchenko V, Crimmins J, Magrabi F, Gallego B, Coiera E. Impact of  a web-based personally controlled health management system on influenza vaccination and health services utilization rates: a randomized controlled trial. J Am Med Inform Assoc. 2012 Sep 1; 19(5):719-27.

143. Lau JT, Au DW, Tsui HY, Choi KC. Prevalence and determinants of influenza vaccination in the Hong Kong Chinese adult population. Am J Infect Control. 2012 Sep; 40(7):e225-7.

144. Leal J, Vanderkooi OG, Church DL, Macdonald J, Tyrrell GJ, Kellner JD. Eradication of Invasive Pneumococcal Disease due to the Seven-valent Pneumococcal Conjugate Vaccine Serotypes in Calgary, Alberta. Pediatr Infect Dis J. 2012 Sep; 31(9):e169-e175.

145. Leask J, Kinnersley P, Jackson C, Cheater F, Bedford HE, Rowles G. Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 2012 Sep 21;12(1):154. [Epub ahead of print].

146. Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS; the VRC 304 and VRC 305 Study Teams. H5 DNA Influenza Vaccination is Immunogenic by Intramuscular and Intradermal Routes in Humans. Clin Vaccine Immunol. 2012 Sep 5. [Epub ahead of print].

147. Lee BY, Bacon KM, Wateska AR, Bottazzi ME, Dumonteil E, Hotez PJ. Modeling the economic value of a Chagas' disease therapeutic vaccine. Hum Vaccin Immunother. 2012 Sep 1; 8(9). [Epub ahead of print]

148. Lee WS, Lim BT, Chai PF, Kirkwood CD, Lee JK. Rotavirus genotypes in Malaysia and Universal rotavirus vaccination. Hum Vaccin Immunother. 2012 Sep 28; 8(10). [Epub ahead of print]

149. Leuridan E, Sabbe M, Van Damme P. Measles outbreak in Europe: Susceptibility of infants too young to be immunized. Vaccine. 2012 Sep 7; 30(41):5905-13.

150. Leval A, Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF. Incidence of genital warts in sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis. 2012 Sep; 206(6):860-6.

151. Li F, Wang Q, Zhang L, Su H, Zhang J, Wang T, Huang D, Wu J, Yan Y, Fan D. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area  in northwest China. Vaccine. 2012 Sep 25. [Epub ahead of print].

152. Li L, Saade F, Petrovsky N. The future of human DNA vaccines. J Biotechnol.  2012 Sep 7. [Epub ahead of print].

153. Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana A, Plotkin SA. Measles, mumps, and rubella virus vaccine (M-M-RTMII): A review of 32 years of clinical and postmarketing experience. Vaccine. 2012 Sep 7. [Epub ahead of print].

154. Loew-Baselli A, Pavlova BG, Fritsch S, Poellabauer EM, Draxler W, Kistner O, Behre U, Angermayr R, Neugebauer J, Kirsten K, Förster-Waldl E, Koellges R, Ehrlich HJ, Barrett PN. A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory. Vaccine. 2012 Sep 7; 30(41):5956-66.

155. Loomba RS, Aggarwal S, Shah PH, Arora RR. Influenza vaccination and cardiovascular morbidity and mortality: analysis of 292 383 patients. J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):277-83.  

156. Lown BA, Chen LH, Wilson ME, Sisson E, Gershman M, Yanni E, Jentes ES, Hochberg NS, Hamer DH, Barnett ED. Vaccine administration decision making: the case of yellow Fever vaccine. Clin Infect Dis. 2012 Sep; 55(6):837-43.

157. Lu PJ, Ding H, Black CL. H1N1 and Seasonal Influenza Vaccination of U.S. Healthcare Personnel, 2010. Am J Prev Med. 2012 Sep; 43(3):282-92.

158. Luciani F, Bull RA, Lloyd AR. Next generation deep sequencing and vaccine design: today and tomorrow. Trends Biotechnol. 2012 Sep; 30(9):443-52.

159. Lund N, Andersen A, Monteiro I, Aaby P, Benn CS. No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural  experiment. Vaccine. 2012 Sep 6. pii: S0264-410X(12)01271-6. [Epub ahead of print].

160. Maccannell T, Shugart A, Schneider AK, Lindley MC, Lorick SA, Rao A, Woods LO, Ahmed F, Sinkowitz-Cochran RL. A Qualitative Assessment of a Performance Measure for Reporting Influenza Vaccination Rates among Healthcare Personnel. Infect Control Hosp Epidemiol. 2012 Sep;33(9):945-8.

161. Macdonald NE, Smith J, Appleton M. Risk perception, risk management and safety assessment: What can governments do to increase public confidence in their vaccine system? Biologicals. 2012 Sep; 40(5):384-8.

162. Magnus MC, Vestrheim DF, Nystad W, Håberg SE, Stigum H, London SJ, Bergsaker MA, Caugant DA, Aaberge IS, Nafstad P. Decline in Early Childhood Respiratory Tract Infections in the Norwegian Mother and Child Cohort Study After Introduction of Pneumococcal Conjugate Vaccination. Pediatr Infect Dis J. 2012 Sep; 31(9):951-955.

163. Maisonneuve H, Floret D. [Wakefield's affair: 12 years of uncertainty whereas no link between autism and MMR vaccine has been proved]. Presse Med. 2012 Sep;41(9 Pt 1):827-34.

164. Mannino S, Villa M, Apolone G, Weiss NS, Groth N, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Rothman KJ. Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol. 2012 Sep 15;176(6):527-33.

165. Marchetti E, Mazarin-Diop V, Chaumont J, Martellet L, Makadi MF, Viviani S,  Kulkarni PS, Preziosi MP. Conducting vaccine clinical trials in sub-Saharan Africa: Operational challenges and lessons learned from the Meningitis Vaccine Project. Vaccine. 2012 Sep 16. [Epub ahead of print].

166. Marinoviæ AA, Swaan C, Wichmann O, van Steenbergen J, Kretzschmar M. Effectiveness and Timing of Vaccination during School Measles Outbreak. Emerg Infect Dis. 2012 Sep;18(9):1405-13.

167. Marra F, Young F, Richardson K, Marra CA. A Meta-analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events. Influenza Other Respi Viruses. 2012 Sep 13. [Epub ahead of print].

168. Marshall V, Gruber M. Influenza immunization during pregnancy: US regulatory perspective. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S57-62.

169. Massé R, Désy M. Lay people's interpretation of ethical values related to mass vaccination; the case of A(H1N1) vaccination campaign in the province of Quebec (French Canada). Health Expect. 2012 Sep 28. [Epub ahead of print].

170. Mayer AP, Vegunta S, Files JA. Human Papillomavirus Vaccine for Women over Forty: It's Not Just For Kids. J Womens Health (Larchmt). 2012 Sep; 21(9):982-3.

171. McCauley MM, Kennedy A, Basket M, Sheedy K. Exploring the choice to refuse or delay vaccines: a national survey of parents of 6- through 23-month-olds. Acad Pediatr. 2012 Sep;12(5):375-83.

172. McCormack PL. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (boostrix®): a review of its properties and use as a  single-dose booster immunization. Drugs. 2012 Sep 10; 72(13):1765-91.

173. Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. Vaccines and antibiotic resistance. Curr Opin Microbiol. 2012 Sep 11. [Epub ahead of print].

174. Mitchell R, Ogunremi T, Astrakianakis G, Bryce E, Gervais R, Gravel D, Johnston L, Leduc S, Roth V, Taylor G, Vearncombe M, Weir C; Canadian Nosocomial  Infection Surveillance Program. Impact of the 2009 influenza A (H1N1) pandemic on Canadian health care workers: A survey on vaccination, illness, absenteeism, and  personal protective equipment. Am J Infect Control. 2012 Sep;40(7):611-6.

175. Monto AS, Ohmit SE. Editorial commentary: seasonal influenza vaccines during the 2009 pandemic: help or harm? Clin Infect Dis. 2012 Sep; 55(5):703-5.

176. Moores P, Allan P. Affecting change through continuing education: improving  vaccine administration technique. J Contin Educ Nurs. 2012 Sep;43(9):395-400; quiz 401-2.

177. Moraga-Llop FA, Campins Martí M. [Consensus document on vaccination in the immunocompromised: some considerations]. An Pediatr (Barc). 2012 Sep;77(3):218-9.

178. Mori S, Ueki Y, Hirakata N, Oribe M, Hidaka T, Oishi K. Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis. 2012 Sep 6. [Epub ahead of print].

179. Morin A, Lemaître T, Farrands A, Carrier N, Gagneur A. Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program? Vaccine. 2012 Sep 7;30(41):5921-7.

180. Mousavi-Jazi M, Karlberg H, Papa A, Christova I, Mirazimi A. Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. Vaccine. 2012 Sep 28; 30(44):6225-9.

181. Moustafa M, Aronoff GR, Chandran C, Hartzel JS, Smugar SS, Galphin CM, Mailloux LU, Brown E, Dinubile MJ, Kartsonis NA, Guris D. Phase IIa Study of the  Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis. Clin Vaccine Immunol. 2012 Sep;19(9):1509-16.

182. Mowbray F, Rubin GJ. Notification about seasonal influenza vaccination: what is the best way to increase uptake? Prim Care Respir J. 2012 Sep; 21(3):248-9.

183. Muhammad R, Wong CL, Limdi JK. Vaccinating patients with inflammatory bowel  disease - Primum non nocere. Scand J Gastroenterol. 2012 Sep; 8-9(47):1122-3.

184. Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S33-7.

185. Myers LB, Goodwin R. Using a theoretical framework to determine adults' intention to vaccinate against pandemic swine flu in priority groups in the UK. Public Health. 2012 Sep;126 Suppl 1:S53-6.

186. Nagel G, Weinmayr G, Flohr C, Kleiner A, Strachan DP; ISAAC Phase Two Study  Group. Association of pertussis and measles infections and immunizations with asthma and allergic sensitization in ISAAC Phase Two. Pediatr Allergy Immunol. 2012 Sep 24. [Epub ahead of print].

187. Narula N, Dhillon A, Chauhan U, Marshall J. An audit of influenza vaccination status in adults with inflammatory bowel disease. Can J Gastroenterol. 2012 Sep; 26(9):593-6.

188. Nascimento IP, Leite LC. Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res. 2012 Sep 6. [Epub ahead of print].

189. Norquist J, Khawaja S, Kurian C, Mast TC, Liaw KL, Robertson M, Evans B, Gutsch D, Saddier P. Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance. Hum Vaccin Immunother. 2012 Sep 1; 8(9). [Epub ahead of print].

190. Nowalk MP, Nutini J, Raymund M, Ahmed F, Albert SM, Zimmerman RK. Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project. Vaccine. 2012 Sep 7; 30(41):5978-82.

191. Nyhan B, Reifler J, Richey S. The role of social networks in influenza vaccine attitudes and intentions among college students in the southeastern United States. J Adolesc Health. 2012 Sep; 51(3):302-4.

192. O'Leary ST, Suh CA, Marin M; the Vaccine Policy Collaborative Initiative. Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: What do primary care physicians think? Vaccine. 2012 Sep 10. [Epub ahead of print].

193. O'Mahony JF. Re: Cost-effectiveness of pertussis booster vaccination in the  Netherlands. Vaccine. 2012 Sep 28. [Epub ahead of print].

194. Oftadeh S, Gidding HF, Gilbert GL. Laboratory surveillance of invasive pneumococcal disease in New South Wales, Australia, before and after introduction of 7-valent conjugate vaccine: reduced disease, but not antibiotic resistance rates. Epidemiol Infect. 2012 Sep 25:1-10. [Epub ahead of print]

195. Okada K, Iwasa T; JE Vaccine Clinical Study Group, Namazue J, Akechi M, Ueda S. Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK(®)V) in children. Vaccine. 2012 Sep 7; 30(41):5967-72.

196. Oldach BR, Katz ML. Ohio Appalachia Public Health Department Personnel: Human Papillomavirus (HPV) Vaccine Availability, and Acceptance and Concerns Among Parents of Male and Female Adolescents. J Community Health. 2012 Sep 12. [Epub ahead of print].

197. Omer SB, Richards JL, Ward M, Bednarczyk RA. Vaccination policies and rates  of exemption from immunization, 2005-2011. N Engl J Med. 2012 Sep 20; 367(12):1170-1.

198. Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, Kumararatne D, Harville TO, Hesterberg P, Koleilat M, McGhee S, Perez EE, Raasch  J, Scherzer R, Schroeder H, Seroogy C, Huissoon A, Sorensen RU, Katial R. Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012 Sep; 130(3 Suppl):S1-S24.

199. Orcurto A, Pascual M, Hoschler K, Aubert V, Meylan P, Manuel O. Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients. Transplantation. 2012 Sep 27; 94(6):630-636.

200. Ortiz JR, Neuzil KM, Ahonkhai VI, Gellin BG, Salisbury DM, Read JS, Adegbola RA, Abramson JS. Translating vaccine policy into action: A report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine. 2012 Sep 28. [Epub ahead of print].

201. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Quantifying the efficacy of  influenza vaccines: Authors' reply. Lancet Infect Dis. 2012 Sep; 12(9):660-1.

202. Oxford JS. Effectiveness of H1N1 vaccination in Scotland, UK. Lancet Infect  Dis. 2012 Sep;12(9):653-4.

203. Pace D. Glycoconjugate vaccines. Expert Opin Biol Ther. 2012 Sep 20. [Epub ahead of print]

204. Pakkanen SH, Kantele JM, Kantele A. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine. 2012 Sep 14; 30(42):6047-53.

205. Pan SC, Kung HC, Kao TM, Wu H, Dong SX, Hu MH, Chou AH, Chong P, Hsieh SM, Chang SC. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan. J Microbiol Immunol Infect. 2012 Sep 26. [Epub ahead of print].

206. Paranthaman K, Bunce A. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy. Epidemiol Infect. 2012 Sep; 140(9):1612-6.

207. Pasetti MF, Levine MM. Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clin Vaccine Immunol. 2012 Sep 19. [Epub ahead of print].

208. Pathirana RD, Bredholt G, Akselsen PE, Pedersen GK, Cox RJ. A(H1N1)pdm09 vaccination of healthcare workers: Improved immune responses in low responders following revaccination. J Infect Dis. 2012 Sep 11. [Epub ahead of print].

209. Patterson BW, Khare RK, Courtney DM, Lee TA, Kyriacou DN. Cost-effectiveness of influenza vaccination of older adults in the ED setting. Am J Emerg Med. 2012 Sep; 30(7):1072-9.

210. Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ. B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody. J Immunol. 2012 Sep 1; 189(5):2673-81.

211. Picazo JJ, Alonso LM, Arístegui J, Bayas JM, Sanz J, Del Amo P, Cobos JL, Rodríguez-Salazar J, Sánchez-Pastor M, de la Cámara R, Carratalá J, Cañada JL, González-Del Castillo J, Aldaz P, Pérez-Escanilla F, Barberán J, Rodríguez A, Vigil-Escribano D, Espinosa-Arranz J, Blanquer J, González-Romo F. [Consensus Document on vaccination against influenza in health care workers]. Rev Esp Quimioter. 2012 Sep; 25(3):226-39.

212. Pilger D, Nguipdop-Djomo P, Abubakar I, Elliman D, Rodrigues LC, Watson JM,  Eastman V, Mangtani P. BCG vaccination in England since 2005: a survey of policy  and practice. BMJ Open. 2012 Sep 10; 2(5).

213. Plosker GL. Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (RotarixTM) in Developed Countries†. Drugs R D. 2012 Sep 28. [Epub ahead of print].

214. ollock AM, Brhlikova P, Mattheij I. Author's Response: HPV vaccination in India. J R Soc Med. 2012 Sep; 105(9):366-7.

215. Posfay-Barbe KM, Pittet LF, Sottas C, Grillet S, Wildhaber BE, Rodriguez M,  Kaiser L, Belli DC, McLin VA, Siegrist CA. Varicella-Zoster Immunization in Pediatric Liver Transplant Recipients: Safe and Immunogenic. Am J Transplant. 2012 Sep 20. [Epub ahead of print].

216. Poyot T, Flusin O, Diserbo M, Iseni F, Peinnequin A. Evaluation of normalization strategies for qPCR quantitation of intracellular viral DNA: The example of Vaccinia virus. J Virol Methods. 2012 Sep 5; 186(1-2):176-183. [Epub ahead of print].

217. Pérez-Vilar S, Gutiérrez-Gimeno MV, Rodríguez-Galán MA, Díez-Domingo J, Puig-Barberà J, Gomar-Fayos J, Alguacil-Ramos AM. [Suspected adverse events to measles, mumps and rubella vaccine reported to the Community of Valencia Pharmacovigilance Centre.]. An Pediatr (Barc). 2012 Sep 13. pii: S1695-4033(12)00340-2.[Epub ahead of print].

218. Quach S, Hamid JS, Pereira JA, Heidebrecht CL, Deeks SL, Crowcroft NS, Quan  SD, Brien S, Kwong JC. Influenza vaccination coverage across ethnic groups in Canada. CMAJ. 2012 Sep 10. [Epub ahead of print].

219. Quadri-Sheriff M, Hendrix KS, Downs SM, Sturm LA, Zimet GD, Finnell SM. The  role of herd immunity in parents' decision to vaccinate children: a systematic review. Pediatrics. 2012 Sep; 130(3):522-30.

220. Racine NM, Pillai Riddell RR, Flora D, Garfield H, Greenberg S. A longitudinal examination of verbal reassurance during infant immunization: occurrence and examination of emotional availability as a potential moderator*. J Pediatr Psychol. 2012 Sep; 37(8):935-44.

221. Ramakrishnan A, Althoff KN, Lopez JA, Coles CL, Bream JH. Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines. Cytokine. 2012 Sep 15. [Epub ahead of print].

222. Read JS, Riley L. Progress in overcoming barriers to influenza immunization of pregnant women. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S1-2.

223. Rebmann T, Elliott MB, Reddick D, D Swick Z. US school/academic institution  disaster and pandemic preparedness and seasonal influenza vaccination among school nurses. Am J Infect Control. 2012 Sep; 40(7):584-9.

224. Rebmann T, Wright KS, Anthony J, Knaup RC, Peters EB. Seasonal and H1N1 influenza vaccine compliance and intent to be vaccinated among emergency medical  services personnel. Am J Infect Control. 2012 Sep; 40(7):632-6.

225. Retrouvey M, Koch LH, Williams JV. Gianotti-crosti syndrome after childhood  vaccination. Pediatr Dermatol. 2012 Sep; 29(5):666-8.

226. Ribeiro AC, Laurindo IM, Guedes LK, Saad CG, Moraes JC, Silva CA, Bonfa E. Abatacept severely reduces the immune response to pandemic 2009 influenza A/H1N1  vaccination in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken).  2012 Sep 4. [Epub ahead of print].

227. Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, Jones TR, Arora A. A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine. 2012 Sep 21; 30(43):6163-74.

228. Ridda I, Yin JK, King C, Raina Macintyre C, McIntyre P. The importance of pertussis in older adults: A growing case for reviewing vaccination strategy in the elderly. Vaccine. 2012 Sep 12. [Epub ahead of print].

229. Roca A, Bottomley C, Hill PC, Bojang A, Egere U, Antonio M, Darboe O, Greenwood BM, Adegbola RA. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clin Infect Dis. 2012 Sep; 55(6):816-24.

230. Romano M, Huygen K. An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time. Expert Opin Biol Ther. 2012 Sep 8. [Epub ahead of print].

231. Rositch AF, Hudgens MG, Backes DM, Moses S, Agot K, Nyagaya E, Snijders PJ,  Meijer CJ, Bailey RC, Smith JS. Vaccine-Relevant Human Papillomavirus (HPV) Infections and Future Acquisition of High-Risk HPV Types in Men. J Infect Dis. 2012 Sep; 206(5):669-77.

232. Rouleau I, De Serres G, Drolet JP, Banerjee D, Lemire C, Moore A, Paradis L, Alizadhefar R, Roches AD, Chan ES, Stark D, Benoit M, Skowronski DM; PCIRN (Public Health Agency of Canada-Canadian Institutes for Health Research Influenza Research) Network. Allergic symptoms after pandemic influenza vaccination rarely  mediated by vaccine-specific IgE. J Allergy Clin Immunol. 2012 Sep 5. [Epub ahead of print].

233. Ruck RC, Eberly MD. Development of pneumococcal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol. 2012 Sep 12. [Epub ahead of print].

234. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012 Sep 10. [Epub ahead of print].

235. Safan M, Kretzschmar M, Hadeler KP. Vaccination based control of infections  in SIRS models with reinfection: special reference to pertussis. J Math Biol. 2012 Sep 5. [Epub ahead of print].

236. Sawyer MH, Peddecord KM, Wang W, Deguire M, Miskewitch-Dzulynsky M, Vuong DD. A public health initiative to increase annual influenza immunization among hospital health care personnel: The San Diego Hospital Influenza Immunization Partnership. Am J Infect Control. 2012 Sep;40(7):595-600.

237. Schaetti C, Ali SM, Hutubessy R, Khatib AM, Chaignat CL, Weiss MG. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar. Hum Vaccin  Immunother. 2012 Sep 1;8(9). [Epub ahead of print].

238. Schlaudecker EP, McNeal MM, Dodd CN, Ranz JB, Steinhoff MC. Pregnancy Influences the Antibody Response to Trivalent Influenza Immunization. J Infect Dis. 2012 Sep 14. [Epub ahead of print]

239. Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, Morrison VA,  Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman C, Marques A, Toney J, Keller PM, Li X, Chan IS, Annunziato P; for the Shingles Prevention Study Group. Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy. Clin Infect Dis. 2012 Sep 12. [Epub ahead of print].

240. Schoub BD. Introduction of inactivated polio vaccine (IPV) into the routine  immunization schedule of South Africa. Vaccine. 2012 Sep 7; 30 Suppl 3:C35-7.

241. Schoub BD, Mphahlele MJ, Ngcobo NJ, Hoosen AA, Meheus A. Introducing new vaccines into the South African national immunisation programme - A case study. Vaccine. 2012 Sep 7; 30 Suppl 3:C1-2.

242. Schult TM, Awosika ER, Hodgson MJ, Hirsch PR, Nichol KL, Dyrenforth SR, Moore SC. Innovative approaches for understanding seasonal influenza vaccine declination in healthcare personnel support development of new campaign strategies. Infect Control Hosp Epidemiol. 2012 Sep; 33(9):924-31.

243. Schure RM, Hendrikx LH, de Rond LG, Oztürk K, Sanders EA, Berbers GA, Buisman AM. T-cell responses pre and post the 5th consecutive acellular pertussis vaccine in Dutch children 4 years of age. Clin Vaccine Immunol. 2012 Sep 26. [Epub ahead of print].

244. Schütz K, Hughes RG, Parker A, Quinti I, Thon V, Cavaliere M, Würfel M, Herzog W, Gessner JE, Baumann U. Kinetics of IgM and IgA Antibody Response to 23-Valent Pneumococcal Polysaccharide Vaccination in Healthy Subjects. J Clin Immunol. 2012 Sep 25. [Epub ahead of print].

245. Seale H, Kaur R, Macintyre CR. Understanding Australian healthcare workers'  uptake of influenza vaccination: examination of public hospital policies and procedures. BMC Health Serv Res. 2012 Sep 19; 12(1):325. [Epub ahead of print].

246. Seheri LM, Page NA, Mawela MP, Mphahlele MJ, Steele AD. Rotavirus vaccination within the South African Expanded Programme on Immunisation. Vaccine. 2012 Sep 7; 30 Suppl 3:C14-20.

247. Shahram S, Pielak K. Establishing physician advocates for human papillomavirus vaccination in British Columbia. Can Fam Physician. 2012 Sep; 58(9):e514-20.

248. Sharma SK, Pichichero ME. Functional deficits of pertussis-specific CD4(+) T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012 Sep; 169(3):281-91.

249. Shavell VI, Moniz MH, Gonik B, Beigi RH. Influenza immunization in pregnancy: overcoming patient and health care provider barriers. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S67-74.

250. Shim E, Chapman GB, Townsend JP, Galvani AP. The influence of altruism on influenza vaccination decisions. J R Soc Interface. 2012 Sep 7; 9(74):2234-43.

251. Silva M, Humar A, Shapiro AJ, Senior P, Hoschler K, Baluch A, Wilson LE, Kumar D. Humoral Immune Response following Seasonal Influenza Vaccine in Islet Transplant recipients. Cell Transplant. 2012 Sep 21. [Epub ahead of print].

252. Simpson CR, McMenamin J. Pandemic influenza vaccination for healthcare workers in primary care: good progress, but higher uptake required. Prim Care Respir J. 2012 Sep; 21(3):246-7.

253. Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. Lancet Infect Dis. 2012 Sep; 12(9):696-702.

254. Singleton R, Wenger J, Klejka JA, Bulkow LR, Thompson A, Sarkozy D, Emini EA, Gruber WC, Scott DA. The 13-Valent Pneumococcal Conjugate Vaccine for Invasive Pneumococcal Disease in Alaska Native Children: Results of a Clinical Trial. Pediatr Infect Dis J. 2012 Sep 20. [Epub ahead of print]

255. Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, Dionne M, Sabaiduc S, Gardy JL, Li G, Bastien N, Petric M, Boivin G, Li Y. Cross-reactive and Vaccine-Induced Antibody to an Emerging Swine-Origin Variant of Influenza A Virus Subtype H3N2 (H3N2v). J Infect Dis. 2012 Sep 7. [Epub ahead of print].

256. Smit R. Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults. Vaccine. 2012 Sep 28; 30(44):6301-6.

257. Smith SG, Lecher S, Blitz R, Locht C, Dockrell HM. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination. Eur J Immunol. 2012 Sep; 42(9):2511-22.:

258. Son J, Lee SB, Lee DW, Kim IY, Lee SJ, Lee SM, Song SH, Seong EY, Kwak IS. Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients. Clin Exp Nephrol. 2012 Sep 19. [Epub ahead of print].

259. Soriano A, Manna R. Quantifying the efficacy of influenza vaccines. Lancet Infect Dis. 2012 Sep; 12(9):659-60.

260. Soyemi K, Howland J, Lee D. Seasonal influenza vaccine compliance and use of declination forms. Infect Control Hosp Epidemiol. 2012 Sep; 33(9):962-3.

261. Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd  S, Louw C, Kirsten M, Aspinall S, Van Doorn LJ, Bouckenooghe A, Suryakiran PV, Han HH. Human rotavirus vaccine RotarixTM provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.  BMC Infect Dis. 2012 Sep 13; 12(1):213.

262. Steinhoff MC, Omer SB. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol. 2012 Sep; 207(3 Suppl):S21-7.

263. Stoecker C, Hampton LM, Moore MR. 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series. Vaccine. 2012 Sep 28; 30(44):6256-62.

264. Stöcker P, Dehnert M, Schuster M, Wichmann O, Deleré Y. Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Hum Vaccin Immunother. 2012 Sep 20;9(1). [Epub ahead of print].

265. Sulsky SI, Luippold R, Garman P, Hughes H, Boyko EJ, Maynard C, Amoroso PJ.  Disability among US Army Veterans vaccinated against anthrax. Vaccine. 2012 Sep 21; 30(43):6150-6.

266. Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W, Law B; for Members of the Canadian Immunization Monitoring Program, Active (IMPACT). The Effect of Funded Varicella Immunization Programs on Varicella-related Hospitalizations in IMPACT Centers, Canada, 2000-2008. Pediatr Infect Dis J. 2012 Sep; 31(9):956-963.

267. Tennis P, Toback SL, Andrews EB, McQuay LJ, Ambrose CS. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season. Vaccine. 2012  Sep 14;30(42):6099-102.

268. The Practice Committee of the American Society for Reproductive Medicine. Vaccination guidelines for female infertility patients: a committee opinion. Fertil Steril. 2012 Sep 12. [Epub ahead of print].

269. Theodoridou M, Dargenta G, Aptouramani M, Papastergiou P, Katsiaflaka A, Theodoridou K, Hadjichristodoulou C. Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008). Adv Prev Med. 2012; 2012:303846.

270. Thomas-Crusells J, McElhaney JE, Aguado MT. Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization. Vaccine. 2012 Sep 14; 30(42):6007-12.

271. Tobudic S, Plunger V, Sunder-Plassmann G, Riegersperger M, Burgmann H. Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients. PLoS One. 2012;7(9):e46133.

272. Tomljenovic L, Shaw CA. Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety? Am J Public Health. 2012 Sep; 102(9):e13-4.

273. Torensma R. Quantifying the efficacy of influenza vaccines. Lancet Infect Dis. 2012 Sep; 12(9):656.

274. Trivedi B. Chronic disease vaccines need shot in the arm. Science. 2012 Sep 21; 337(6101):1479-81.

275. Trubiano JA, Holmes NE, Williams DS, Ng J, Chua K, Howden BP. Coxiella burnetii endocarditis after Q fever vaccination. J Med Microbiol. 2012 Sep 14. [Epub ahead of print].

276. Truong VA. The pediatric vaccine stockpiling problem. Vaccine. 2012 Sep 21; 30(43):6175-9.

277. Trück J, Lazarus R, Jonsdottir I, Klugman KP, Pollard AJ. Pneumococcal Polysaccharide Vaccine Efficacy and Routine Use of Conjugate Vaccines in Infants: There Is No Need for a Vaccine Program in Older Adults at Present. Clin Infect Dis. 2012 Sep 12. [Epub ahead of print].

278. Uno S, Kimachi K, Matsuo F, Miyazaki K, Oohama A, Kei J, Nishimura T, Odoh K, Kino Y. Cross-reactive Antibody Response to the Pandemic A (H1N1) 2009 Influenza Virus induced by vaccination with a seasonal trivalent influenza vaccine: A Longitudinal Study of Three Influenza Seasons in Japan. Microbiol Immunol. 2012 Sep 26. [Epub ahead of print].

279. van der Velden MV, Aichinger G, Pöllabauer EM, Löw-Baselli A, Fritsch S, Benamara K, Kistner O, Müller M, Zeitlinger M, Kollaritsch H, Vesikari T, Ehrlich HJ, Barrett PN. Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1  influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming. Vaccine. 2012 Sep 21;30(43):6127-35.

280. Van Rossem I, Vandevoorde J, Buyl R, Deridder S, Devroey D. Notification about influenza vaccination in Belgium: a descriptive study of how people want to be informed. Prim Care Respir J. 2012 Sep; 21(3):308-12.

281. Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME. Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology. 2012 Sep; 23(5):751-61.

282. Verma P. Erythema Multiforme Possibly Triggered by Rabies Vaccine in a 10-Year-Old Boy. Pediatr Dermatol. 2012 Sep 7. [Epub ahead of print].

283. Vesikari T, Pepin S, Kusters I, Hoffenbach A, Denis M. Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 mo to 17 y of age. Hum Vaccin Immunother. 2012 Sep 1;8(9). [Epub ahead of print].

284. Visser A, Hoosen A. Haemophilus influenzae type b conjugate vaccines - A South African perspective. Vaccine. 2012 Sep 7; 30 Suppl 3:C52-7.

285. Visser A, Hoosen A. Combination vaccines in the South African setting. Vaccine. 2012 Sep 7;30 Suppl 3:C38-44.

286. Vågberg M, Kumlin U, Svenningsson A. Humoral immune response to influenza vaccine in natalizumab-treated MS patients. Neurol Res. 2012 Sep; 34(7):730-3.

287. Walhart T. Parents, adolescents, children and the human papillomavirus vaccine: a review. Int Nurs Rev. 2012 Sep; 59(3):305-11.

288. Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of an Incomplete RotaTeq® (RV5) Vaccination Regimen in Preventing Rotavirus Gastroenteritis in the United States. Pediatr Infect Dis J. 2012 Sep 25. [Epub ahead of print].

289. Wang SM, Tsai MH, Lei HY, Wang JR, Liu CC. The regulatory T cells in anti-influenza antibody response post influenza vaccination. Hum Vaccin Immunother. 2012 Sep 1; 8(9). [Epub ahead of print].

290. Watanabe T, Hashidate H, Hirayama Y, Iinuma Y. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis. Eur J Pediatr. 2012 Sep; 171(9):1409-11.

291. Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, Kapiga S, Mayaud P, de Sanjosé S, Wight D, Changalucha J, Hayes R. Human papillomavirus vaccination in tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis. 2012 Sep; 206(5):678-86.

292. Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective. BMC Infect Dis. 2012 Sep 7; 12(1):207.

293. Welaga P, Nielsen J, Adjuik M, Debpuur C, Ross DA, Ravn H, Benn CS, Aaby P.  Non-specific effects of diphtheria-tetanus-pertussis and measles vaccinations? An analysis of surveillance data from Navrongo, Ghana. Trop Med Int Health. 2012 Sep 24. [Epub ahead of print].

294. Whelan PJ, Walwyn R, Gaughran F, Macdonald A. Impact of the demand for 'proxy assent' on recruitment to a randomised controlled trial of vaccination testing in care homes. J Med Ethics. 2012 Sep 1. [Epub ahead of print].

295. Wikström A, Brönnegård M, Cassel T, Young C. Pre-vaccination incidence of genital warts in 15-23-year-old women and men attending youth clinics in Stockholm, Sweden. Scand J Infect Dis. 2012 Sep; 44(9):678-82.

296. Williams DJ, Edwards KM, Payne DC, Manning J, Parashar UD, Lopman BA. Decline in Gastroenteritis-Related Triage Calls After Rotavirus Vaccine Licensure. Pediatrics. 2012 Sep 10. [Epub ahead of print].

297. Wilson K, Hawken S, Kwong JC, Deeks SL, Crowcroft NS, Manuel D. Vaccine and  Immunization Surveillance in Ontario (VISION) - Using linked health administrative databases to monitor vaccine safety. Vaccine. 2012 Sep 21; 30(43):6115-20.

298. Woldeamanuel YW. Tetanus in Ethiopia: Unveiling the Blight of an Entirely Vaccine-Preventable Disease. Curr Neurol Neurosci Rep. 2012 Sep 21. [Epub ahead of print].

299. Xu A, Xu Q, Fang X, Bialek S, Wang C. Varicella vaccine uptake in Shandong province, China. Hum Vaccin Immunother. 2012 Sep 1; 8(9). [Epub ahead of print].

300. Yin JK, Khandaker G, Rashid H, Dwyer DE, Booy R. Quantifying the efficacy of influenza vaccines. Lancet Infect Dis. 2012 Sep; 12(9):658-9.

301. Yin L, Calvo-Calle JM, Dominguez-Amorocho O, Stern LJ. HLA-DM Constrains Epitope Selection in the Human CD4 T Cell Response to Vaccinia Virus by Favoring  the Presentation of Peptides with Longer HLA-DM-Mediated Half-Lives. J Immunol. 2012 Sep 10. [Epub ahead of print].

302. Zepke JC Jr, Hayney MS. The vital role of influenza vaccination of health care personnel. J Am Pharm Assoc (2003). 2012 Sep 1; 52(5):714-6.

303. Zhang J, While AE, Norman IJ. Development and testing of an instrument to assess nurses' knowledge, risk perception, health beliefs and behaviours related  to influenza vaccination. J Clin Nurs. 2012 Sep; 21(17-18):2636-46.

304. Zhang J, While AE, Norman IJ. Seasonal influenza vaccination knowledge, risk perception, health beliefs and vaccination behaviours of nurses. Epidemiol Infect. 2012 Sep; 140(9):1569-77.

305. Zhu VJ, Grannis SJ, Tu W, Rosenman MB, Downs SM. Evaluation of a clinical decision support algorithm for patient-specific childhood immunization. Artif Intell Med. 2012 Sep; 56(1):51-7.

306. Zimmerman RK, Wiringa AE, Nowalk MP, Lin CJ, Rousculp MD, Mitgang EA, Lee BY. The comparative value of various employer-sponsored influenza vaccination clinics. J Occup Environ Med. 2012 Sep; 54(9):1107-17.

307. Zlamy M, Hofer J, Elias J, Vogel U, Frosch M, Jungraithmayr T, Zimmerhackl LB, Prelog M. Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. Pediatr Transplant. 2012 Sep; 16(6):E246-50.

 [top]